Samfine Creation Holdings Group (SFHG) Stock Price, News & Analysis

Company Overview

Samfine Creation Holdings Group Limited is a precision medicine and molecular diagnostics company that focuses on advancing genomic applications for clinical and research use. The company provides next-generation sequencing (NGS) services, genetic disease screening, non-invasive prenatal testing (NIPT) and oncology liquid biopsy solutions. By integrating laboratory services, proprietary reagent kits and proprietary bioinformatics platforms, Samfine Creation delivers end-to-end genetic testing workflows designed to support hospitals, medical institutions and research organizations.

In addition to its core sequencing capabilities, Samfine Creation develops personalized health management programs that leverage pharmacogenomic profiling and risk assessment tools. The company’s product portfolio includes NGS-based panels for rare disease diagnostics, customized research panels, and software for data interpretation and reporting. These offerings enable clinicians and researchers to make informed decisions on early disease detection, treatment planning and therapeutic monitoring.

Founded with a mission to democratize access to precision healthcare, Samfine Creation has established a network of laboratories and service centers across major Chinese cities, including Beijing, Shanghai and Xi’an. The company collaborates with leading academic institutions and regional healthcare providers to expand its testing coverage and support public health initiatives. In addition, Samfine Creation is exploring strategic partnerships in the Asia-Pacific region to extend its genomic services globally.

The leadership team is composed of industry veterans with extensive experience in genomics, diagnostics and healthcare management. Chairman and Chief Executive Officer Yi Zhang brings more than two decades of operational and research expertise, while Chief Scientific Officer Dr. Li Wang leads the company’s R&D efforts. Together, they oversee a multidisciplinary team dedicated to innovation in molecular diagnostics and precision medicine.

Key Stats

• Today's Range: $0.92 to $0.95
• 50-Day Range: $0.66 to $0.96
• 52-Week Range: $0.55 to $24.00
• Volume: 96,921 shs
• Average Volume: 864,263 shs
• Market Capitalization: $18.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SFHG Stock Analysis - Frequently Asked Questions

How have SFHG shares performed this year?

Samfine Creation Holdings Group's stock was trading at $1.21 at the beginning of 2025. Since then, SFHG stock has decreased by 23.8% and is now trading at $0.9222.

When did Samfine Creation Holdings Group IPO?

Samfine Creation Holdings Group (SFHG) raised $9 million in an IPO on Tuesday, October 15th 2024. The company issued 2,000,000 shares at a price of $4.00-$5.00 per share. Cathay Securities and Revere Securities acted as the underwriters for the IPO.

How do I buy shares of Samfine Creation Holdings Group?

Shares of SFHG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: PRINTING - COMMRL
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:SFHG
• Previous Symbol: NASDAQ:SFHG
• CIK: 1926792
• Web: www.1398.cn
• Phone: 852-3589-1500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 20,300,000
• Free Float: N/A
• Market Cap: $19.00 million
• Optionable: N/A
• Beta: N/A